Regeneron Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.11.14	Regeneron, Sanofi Announce New Positive Results From Six Phase 3 ODYSSEY Trials (RTTNews)
18.11.14	Regeneron & Bayer HealthCare's Eylea Gets Japanese Nod For Macular Edema (RTTNews)
11.11.14	Regeneron, Sanofi Say Phase 2b Trial Of Dupilumab Meets Primary Endpoint (RTTNews)
04.11.14	Regeneron Pharmaceuticals Q3 Profit Falls - Quick Facts (RTTNews)
20.10.14	Regeneron, Sanofi Begins Phase 3 Trial Of Dupilumab - Quick Facts (RTTNews)
20.10.14	Sanofi, Regeneron Begin Phase 3 Study For Eczema Drug Dupilumab (RTTNews)
17.10.14	Amgen Files Patent Infringement Lawsuit Against Sanofi And Regeneron (RTTNews)
17.10.14	Regeneron Pharma's EYLEA Injection Shows Greater Gains In Visual Acuity (RTTNews)
07.10.14	ACT Opens Wallet, ADHD Craters, CMRX Focuses On Ebola, REGN Gets FDA Nod (RTTNews)
07.10.14	Regeneron Pharma Says FDA Approves Expanded Use Of Eylea (RTTNews)
30.09.14	Regeneron, Sanofi Report Positive Phase 2 Dupilumab Results In CSwNP (RTTNews)
30.09.14	Regeneron, Sanofi Report Positive Phase 2 Top-line Dupilumab Results For CSwNP (RTTNews)
22.09.14	Bayer' EYLEA Gets Approval In Japan To Treat Myopic Choroidal Neovascularization (RTTNews)
04.09.14	Regeneron: Bayer's Japan Unit Submits Application For EYLEA Injection In Japan (RTTNews)
31.08.14	Sanofi, Regeneron Report Positive Results From Four Pivotal Alirocumab Trials (RTTNews)
25.08.14	Regeneron, Sanofi To Present Results From Four Phase 3 Alirocumab Trials At ESC (RTTNews)
05.08.14	Regeneron Pharma Q2 Profit Increases - Quick Facts (RTTNews)
30.07.14	Sanofi And Regeneron: 9 Phase 3 ODYSSEY Trials Of Alirocumab Met Primary Goal (RTTNews)
30.07.14	ADMP Awaits Decision, REGN Can Catch Your Eye, SQNM Does A Deal, ZLTQ Goes Cool (RTTNews)
18.07.14	Regeneron Reports Results From Phase3 Trial Of EYLEA Injection For DME Treatment (RTTNews)
10.07.14	The Rise And Rise Of Regeneron... (RTTNews)
09.07.14	Regeneron, Sanofi Announce Positive Results From Ph 2b Study Of Dupilumab (RTTNews)
12.06.14	Sanofi, Regeneron Announce Detailed Data From Positive Sarilumab Phase 3 Trial (RTTNews)
08.05.14	Regeneron Q1 GAAP Profit Down - Quick Facts (RTTNews)
05.05.14	Regeneron, Avalanche To Develop Novel Gene Therapy Products In Ophthalmology (RTTNews)
01.04.14	Sanofi, Regeneron Report Positive Results On Alirocumab Phase 2 Japanese Study (RTTNews)
27.03.14	BioMed Realty, L.P. -- Moody's revises BioMed's outlook to positive (Moodys)
03.03.14	Bayer Submits VEGF Trap-Eye To Treat Diabetic Macular Edema In Japan (RTTNews)
25.02.14	BIOL Has Reason To Smile, CBMG Walks The Talk, CLSN Warms Up, REGN Catches Eyes (RTTNews)
24.02.14	Regeneron Says FDA Accepts For Review SBLA For EYLEA - Quick Facts (RTTNews)
11.02.14	Regeneron Pharma Reports Q4 Net Income Of 0.86 Per Share - Quick Facts (RTTNews)
10.02.14	Regeneron, Bayer Announce Results From Phase 3 VISTA Trial Of EYLEA (RTTNews)
14.01.14	Bayer und Regeneron entwickeln Therapie gegen Makula-Degeneration (Dow Jones)
14.01.14	Regeneron, Bayer To Co-develop Eylea Combination Therapy (RTTNews)
19.12.13	Sanofi, Regeneron To Collaborate With ACC For PCSK9 Inhibitor Clinical Program (RTTNews)
19.12.13	ALIM, PSDV Rally After Iluvien News, GILD Lays Out Plan, REGN Gets FDA Date (RTTNews)
18.12.13	Regeneron: FDA Accepts SBLA For EYLEA - Quick Facts (RTTNews)
22.11.13	Regeneron Says EYLEA Got Approval In Japan - Quick Facts (RTTNews)
22.11.13	Sanofi, Regeneron Report Positive Data With Sarilumab In Phase 3 Arthritis Trial (RTTNews)
22.11.13	Sanofi, Regeneron Report Positive Results With Sarilumab In First Phase 3 Trial (RTTNews)
07.11.13	Bayer HealthCare Submits MAA In European Union For EYLEA Injection (RTTNews)
05.11.13	Regeneron Pharma Q3 GAAP Profit Drops - Quick Facts (RTTNews)
21.10.13	Critical Alerts For Cisco, Chipotle Mexican Grill, Regeneron, SolarCity, and ARM Holdings Released By InvestorsObserver (PR Newswire)
21.10.13	Regeneron Pharma Reports Positive Topline Results For EYLEA Injection (RTTNews)
21.10.13	Regeneron Reports Positive Phase 3 Data for EYLEA® (aflibercept) Injection in Macular Edema Following Branch Retinal Vein Occlusion (PR Newswire)
16.10.13	Dividend Announcements, Earnings Release Scheduled, and Data Presentations from Clinical Studies - Research Report on Questcor, Regeneron, NPS, Incyte, and Nektar (PR Newswire)
16.10.13	Sanofi macht bei Entwicklung von neuem Cholesterinsenker Fortschritte (dpa-afx)
16.10.13	Sanofi, Regeneron Say Alirocumab Significantly Reduces Bad Cholesterol (RTTNews)
23.09.13	Conference Calls, New Appointments, Upcoming Presentations, Prospectus Filings and Acquisition Deal Updates - Research Report on Johnson & Johnson, WellPoint, Regeneron, Onyx, and MannKind (PR Newswire)
19.09.13	Critical Alerts For Cisco Systems, Petroleo Brasileiro S.A., General Motors (GM), Regeneron Pharmaceuticals, and Total S.A. Released By InvestorsObserver (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	93.29	1.90 %	K V
Swisscom	567.00	1.43 %	K V
Roche Hldg G	263.40	1.31 %	K V
Sika	224.10	1.27 %	K V
Holcim	96.72	0.98 %	K V
CieFinRichemont	165.10	-0.30 %	K V
Sonova Hldg	281.70	-0.32 %	K V
Lonza Grp	564.20	-1.74 %	K V
Part Grp Hldg	1’154.50	-1.83 %	K V
UBS Group	27.09	-3.28 %	K V

mehr

01.04.25		Zuversicht in New York: NASDAQ 100 zum Ende des Dienstagshandels mit positivem Vorzeichen
25.03.25		Börse New York: S&P 500 beendet die Sitzung im Plus
25.03.25		Aufschläge in New York: NASDAQ 100 notiert schlussendlich im Plus
25.03.25		Freundlicher Handel in New York: NASDAQ 100-Anleger greifen nachmittags zu
14.03.25		Optimismus in New York: NASDAQ 100 zum Handelsende mit Gewinnen
14.03.25		Freitagshandel in New York: S&P 500 nachmittags stärker
14.03.25		Aufschläge in New York: NASDAQ 100 nachmittags in Grün
14.03.25		Aufschläge in New York: S&P 500 mit grünem Vorzeichen

01.04.25

Zuversicht in New York: NASDAQ 100 zum Ende des Dienstagshandels mit positivem Vorzeichen

25.03.25

Börse New York: S&P 500 beendet die Sitzung im Plus

25.03.25

Aufschläge in New York: NASDAQ 100 notiert schlussendlich im Plus

25.03.25

Freundlicher Handel in New York: NASDAQ 100-Anleger greifen nachmittags zu

14.03.25

Optimismus in New York: NASDAQ 100 zum Handelsende mit Gewinnen

14.03.25

Freitagshandel in New York: S&P 500 nachmittags stärker